First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA - Yahoo Finance

First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA  Yahoo FinanceRacemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain ...